Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01HL136601, HL090957, R01HL146158, N01-HV-68161, N01-HV-68162, N01-HV-68163, N01-HV-68164, U01 64829, U01 HL649141, U01 HL649241, R03 AG032631, R01HL146158)
- License Information
-
More Information
Article History
Accepted: 8 September 2020
First Online: 28 September 2020
Compliance with Ethical Standards
:
: C.N.B.M receives funding from Abbott Diagnostics, Sanofi (paid through CSMC) and serves as Board of Directors for iRhythm. Andrew Oneglia and Dr. Michael Nelson declare that they have no conflict of interest. Dr. Bairey Merz reports personal fees from iRhythm, personal fees from Med Intelligence, personal fees from Bayer Advisory Board, grants from California Institute for Precision Medicine, grants from CDMRP Department of Defense, grants from NHLBI subcontract to Research Triangle Institute (RTI) International, grants from the NIH, and grants from Sanofi, outside the submitted work.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
